Should PSA levels be “undetectable” at 5 years after successful brachytherapy?

Most brachytherapy centers today use the Phoenix criteria to define clinical success and failure after brachytherapy. But a new paper suggests that brachytherapy can (and perhaps should) use a higher standard for long-term follow-up. … READ MORE …

Prostate cancer news reports: Thursday, January 28, 2010

The news reports today cover studies on:

  • Initial PSA levels and risk for prostate cancer in black and in white Americans
  • 3 T MR imaging, MRI-guided biopsies, and identification of sites of local recurrence after first-line EBRT
  • pT0 disease in men with biopsy-detected prostate cancer
  • Outcomes of immediate surgery compared to deferred treatment … READ MORE …

Prostate cancer news reports: Saturday, July 18, 2009

In today’s news reports you will find items on:

  • Obesity and PSA levels
  • Outcomes after external beam radiation therapy
  • Mitoxantrone + predisone after taxotere failure … READ MORE …

The impact of NSAID use on PSA level and prostate cancer diagnosis

Over the years there have been several studies suggesting that regular use of non-steroidal anti-inflammatory agents (NSAIDs) — the most common being aspirin — can decrease prostate inflammation and prostate cancer risk. Since aspirin and other NSAIDs are commonly used to prevent cardiovascular disease, it will be apparent that there is going to be relatively high use of these agents in the men who are also at some degree of risk for prostate cancer. … READ MORE …